$116.6M in CY2024 Part D spend3.7M claims · 1.0M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Bumetanide used for?
Bumetanide removes excess fluid by acting on the kidneys, used in heart failure and edema.
Is there a generic for Bumetanide?
Yes. 44 ANDAs filed at FDA, 19 generic manufacturers currently shipping.
How much does my plan pay for Bumetanide?
Across 329 Part D plans, Bumetanide averages $0.115/unit (NADAC). Lowest available: $0.115/unit. Highest in distribution: $0.115/unit.
Is Bumetanide on the FDA shortage list?
Yes. Bumetanide is currently listed as an active FDA shortage.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.